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ABSTRACT 
Collision tumors are composed of two or more histologically distinct tumor components occurring at the same anatomic 
location. Collision tumors composed of metastatic carcinoma and lymphoma in the bone marrow is an extremely rare 
occurrence which is not yet reported in literature. We are reporting a case of 61 year old male patient diagnosed as grey zone 
lymphoma in the oral cavity (B cell lymphoma unclassifiable with features intermediate between DLBCL and Burkitt 
lymphoma) and bone marrow showing collision tumor composed of metastatic carcinoma and lymphoma. 
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ollision tumor composed of carcinoma and 
lymphoma in the bone marrow is an extremely 
rare occurrence. Composite tumors are defined as 
tumours in which there are two different intermixed 
histologic types whereas collision tumors are defined as 
multiple synchronous tumours that are histologically 
distinct and in juxtaposition to one another without 
intermingling of tumours [1,2]. The close proximity of the 
two malignancies presents definite serious diagnostic and 
therapeutic challenges.  
Synchronous occurrence of carcinoma and lymphoma 
in the bone marrow is not yet reported in the literature; 
although, there are case reports in other organs [1,2]. 
Immunosuppression may play a role. Further research is 
needed for the proper understanding of this rare 
association. 
 
CASE REPORT 
A 61 year old male presented with swelling in the oral 
cavity of two months duration which was rapidly 
increasing in size. On examination, there was a large 
fungating mass arising from hard palate with ulceration 
and palpable lymphnodes in the left cervical, left axillary, 
and bilateral inguinal region. Other systems were within 
normal limits. Routine blood investigations revealed 
normal blood counts, ESR of 105 mm in the first hour and 
normal LDH levels. CT neck showed a large enhancing 
mass lesion measuring 65x55 mm involving upper lip and 
upper alveolus with underlying bone destruction and 
cervical, right axillary and mediastinal lymphadenopathy 
(Figure 1). Suspicious pulmonary lesion measuring 15x25 
mm was present in the left oblique fissure with mild 
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pleural effusion. Ill defined lytic area noted in bilateral 
posterior iliac bone and L4 vertebra. 
 
Figure 1 - Large enhancing soft tissue mass involving 
upper lip and upper alveolus at midline, the lesion is 
showing destruction of the upper alveolus, hard palate 
and nasal septum, superiorly the lesion is extending to the 
floor of the nasal cavity and inferiorly the lesion is 
projecting into the oral cavity, posteriorly the lesion is 
extending up to the anterior half of hard palate.  
 
Figure 2 – a) Tissue lined by squamous epithelium and 
showing submucosal sheets of atypical lymphoid cells. 
(H&E, x40) b) Atypical lymphoid cells arranged diffusely, 
(H&E, x200) c) Tumor cells are medium sized to large 
with scanty cytoplasm and round to oval nucleus with 
multiple nucleoli, (H&E, x400) d) Tumor cells are CD 20 
positive (IHC, x400) e) BCL 2 positive (IHC, x400) f) 
BCL6 positive (IHC, x400) g) MIB1 labeling index of 
around 100% (IHC, x400). 
Incision biopsy of palatal mass revealed tissue lined by 
squamous epithelium with subepithelium showing a 
neoplasm composed of diffusely arranged cells which 
were medium to large sized with scanty cytoplasm and 
round to oval nucleus with multiple distinct nucleoli. 
Frequent mitotic figures and abundant cellular debris were 
also present. Immunohistochemistry revealed tumor cells 
to be positive for CD 20, LCA and BCL2 with focal 
positivity for BCL6. MIB1 labelling index was around 
100%. The diagnosis of B cell lymphoma, unclassifiable 
with features intermediate between DLBCL and Burkitt 
lymphoma was given (Figure2). 
 
Figure 3 – a) Bone marrow imprint smears showing large 
atypical cells in clusters admixed with small lymphoid 
cells. (H&E, x400) b) Large atypical cells in clusters and 
vague glandular pattern admixed with small lymphoid 
cells (H&E, x1000) c) Small lymphoid cells (H&E, x1000) 
d & e) Bone marrow biopsy showing two histologically 
distinct tumor types with upper half showing the densely 
packed tumor cells and lower half showing tumor cells in 
a desmoplastic stroma (H&E, x100) f) LCA positive tumor 
cells (IHC, x200) g) Cytokeratin positive tumor cells in the 
desmoplastic stroma (IHC, x400)  h) LCA positive tumor 
cells were also CD20 positive (IHC, x200) i) FNAC from 
the lung mass shows atypical large cells in glandular 
pattern, (Giemsa, x1000). 
Bone marrow studies as a part of the staging work up 
revealed cellular imprint smears with clusters of large 
atypical cells with abundant cytoplasm and round to oval 
nucleus and focal sheets of small lymphoid cells. Bone 
marrow biopsy also showed the two populations of cells. 
Morphologically, it was presumed to be the large and 
small cell components of lymphoma. Immuno-
histochemistry done on bone marrow biopsy showed the 
positivity of the large cells for cytokeratin and the small 
cells for CD 45, CD 20 (Figure 3) and negative for CD 5, 
BCL6, cyclin D1 and CD 23. Thus diagnosis of collision 
tumor composed of small B cell lymphoma and metastatic 
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poorly differentiated carcinoma was given CT guided 
FNAC of the lung showed cellular smears showing 
clusters of malignant cells in a necrotic background 
suggestive of non small cell lung carcinoma. 
After discussing the treatment options and prognosis 
with the patient, he was planned on R- CHOP 
chemotherapy regimen for six cycles, but the patient did 
not opt for treatment and was lost to follow-up. 
DISCUSSION 
The synchronous occurrence of multiple malignancies in 
the same patient is a rare event. Synchronous carcinoma 
and lymphoma in the bone marrow is not yet described. 
Multiple malignancies presenting in the same patient 
within six months of diagnosis is referred as synchronous 
tumors. Lymphoproliferative disorders occur as a result of 
immune dysfunction and are often associated with 
epithelial malignancies. Interaction between immune 
system and development of carcinoma has been 
documented [3]. Collission tumors are reported in patients 
with colorectal cancer, non small cell lung cancer, gastric 
and breast cancer. 
Several theories are proposed for the development of 
collision tumor including accidental colliding of two 
independently developed neoplasms, common carcinogen 
theory suggesting a single carcinogen responsible for the 
development of two colliding neoplasms, tumor to tumor 
carcinogenesis theory indicating that one tumor induces 
the development of a second primary tumour [4-6]. 
Common molecular pathways may be involved in the 
development of multiple tumors. Studies have shown that 
due to reduced immunological surveillance caused by 
lymphoma, patients are also predisposed to the 
development of adenocarcinoma [7]. Collision tumors of 
myeloma and prostate cancer and also myeloma and 
merkel cell carcinoma have been described [8,9]]. 
Some studies have pointed out that bone marrow 
microenvironment may play a crucial role. 
Microenvironment of myeloma and prostate cancer has 
shown the important similarities. Both depend on similar 
growth factors and similar chemoattractants for the 
metastasis to bone marrow. Merkel cell carcinoma is 
associated with secondary immunodeficiency affecting B 
and T cell function. Factors contributing to the multiple 
primary tumors may be environmental, genetic or immune 
system dysfunction. One of the primary tumor may cause 
cytokine dysregulation or reduced immune surveillance; 
thus, contributing for localized development of another 
malignancy. 
Considering the rarity of occurrence of collision tumor, 
it is possible that they are just an accidental occurrence. 
Collision tumors are also difficult to diagnose as the 
lymphoid cells may be mistaken for reactive infiltrate. In 
our case, there was discordant infiltrate of lymphoma in 
the bone marrow. Discordant infiltrates may be clonally 
related or unrelated clonally distinct B cell neoplasms [10]. 
Due to the rare occurrence, there are no specific 
recommendations for the therapy. Some recommend 
treatment depending on the dominant tumour, but those 
treatment options appear to exacerbate the other tumour. 
Our patient did not take any treatment and was lost to 
follow up. 
CONCLUSION 
The synchronous occurrence of carcinoma and lymphoma 
in the bone marrow is an interesting rare occurrence and is 
also a diagnostic challenge. High index of suspicion is 
needed as the lymphomatous process may be judged as a 
reactive process secondary to epithelial malignancies. 
Association between immune system and development of 
malignancy can explain the pathogenesis of collision 
tumor. Further genetic studies are necessary to prove a 
common molecular pathway between these two cancers. 
Future studies may provide more information concerning 
the treatment approaches and prognosis of these patients. 
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